Related Experiment Video

Updated: Apr 4, 2026

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

8.7K

IFN-γ Prevents Adenosine Receptor (A2bR) Upregulation To Sustain the Macrophage Activation Response

Heather B Cohen1, Amanda Ward1, Kajal Hamidzadeh1

  • 1Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742; Maryland Pathogen Research Institute, College Park, MD 20742; and.

Journal of Immunology (Baltimore, Md. : 1950)
|September 11, 2015
PubMed

Insights

Interferon-gamma (IFN-γ) primes macrophages for prolonged inflammation by blocking adenosine 2b receptor (A2bR) upregulation. This prevents adenosine

Area of Science:

  • Immunology
  • Cellular Biology
  • Molecular Medicine

Background:

  • Macrophages play a critical role in host defense and inflammation.
  • Interferon-gamma (IFN-γ) priming enhances macrophage inflammatory responses.
  • Extracellular adenosine signaling can modulate macrophage function.

Purpose of the Study:

  • To elucidate the mechanism by which IFN-γ priming prolongs macrophage inflammatory responses.
  • To investigate the role of the adenosine 2b receptor (A2bR) in macrophage immunomodulation.
  • To explore the therapeutic potential of targeting the IFN-γ-A2bR axis in inflammatory diseases.

Main Methods:

  • Macrophage cultures primed with IFN-γ and stimulated with Toll-like receptor (TLR) ligands.
  • Analysis of adenosine 2b receptor (A2bR) expression and function.
  • Pharmacologic inhibition and genetic deletion of A2bR.
  • Overexpression of A2bR in macrophages.

Main Results:

  • TLR stimulation upregulates A2bR, leading to immunosuppressive effects via adenosine.
  • IFN-γ priming prevents A2bR induction, thereby maintaining macrophage pro-inflammatory status.
  • A2bR inhibition or deletion results in hyperinflammation, mimicking IFN-γ effects.
  • A2bR overexpression blunts IFN-γ-mediated effects and promotes immunoregulatory macrophages.

Conclusions:

  • IFN-γ desensitizes macrophages to adenosine by blocking A2bR induction, prolonging antimicrobial responses.
  • This mechanism sustains the classically activated macrophage phenotype beyond transient TLR activation.
  • Targeting the A2bR offers a novel strategy for managing dysregulated macrophage activation in inflammatory diseases.

More Related Videos

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces07:55

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces

Published on: January 7, 2020

7.9K
Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

12.2K

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.3K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
4.5K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.3K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.7K
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.4K